Skip to main content

Advertisement

Table 1 Main demographic and clinical features of the study group

From: May positron emission tomography reveal ectopic or active thymus in preoperative evaluation of non-thymomatous myasthenia gravis?

Variables p-value (n = 68)  
Age, years (median IQR) 39 (25–59)  
Gender   
Male, n. pts (%) 31 (45) 0. 6
Female, n. pts (%) 37 (55)
Anti AchR Ab, nmol/L (median IQR) 3.1 (2.0-4.0)  
Score MG (median IQR) 23 (14–29)  
Symptom duration   
&<12 months, n. pts (%) 20 (29) 0.69
&12 months, n. pts (%) 48 (71)
Oropharyngeal symptoms   
&Yes, n. pts (%) 36 (53) 0.91
&No, n. pts (%) 32 (47)
MGFA classification   
&Class I, n. pts (%) 6 (9) 0.06
&Class II, n. pts (%) 40 (59)
&Class III, n. pts (%) 22 (32)
Histology   
&Hyperplasia, n. pts (%) 27 (40) 0.89
&Atrophia, n. pts (%) 23 (34)
&Normal, n. pts (%) 18 (26)
Thymic germinal centers, n. pts (%) 33 (48)  
&Ectopic tissue, n. pts (%) 37 (54)  
&Ectopic germinal centers, n. pts (%) 23 (34)  
  1. Values are represented as number of patients (percentage) or median and interquartile range (IQR).